Shouksmith, Andrew E <br/><br/>
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.  [electronic resource] 

 -  ACS medicinal chemistry letters  Jan 2020 
 - 56-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1948-5875 
<br/><br/><label>Standard No.: </label>10.1021/acsmedchemlett.9b00471  doi